Читать книгу Tendencias en Investigación Clínica - Galo Peralta Fernández - Страница 17
BIBLIOGRAFÍA
Оглавление– Agencia Española de Medicamentos y Productos Sanitarios. Medidas excepcionales aplicables a los ensayos clínicos para gestionar los problemas derivados de la emergencia por COVID-19. https://www.aemps.gob.es/informa/notasinformativas/medicamentosusohumano-3/2020-medicamentosusohumano-3/medidas-excepcionales-aplicables-a-los-ensayos-clinicos-para-gestionar-los-problemas-derivados-de-la-emergencia-por-covid-19/.
– Agencia Española de Protección de Datos. Sobre la realización de actividades de monitorización remota en ensayos clínicos. https://sedeagpd.gob.es/sede-electronica-web/vistas/infoSede/detallePreguntaFAQ.jsf;jsessionid=__nd_T7AZXJvGb141Qwfmp8BkzB4hdCRxN-fQExU.agpdsedred01n_tmp?idPregunta=FAQ%2F00301.
– Apostolaros M, Babaian D, Corneli A, et al. Legal, Regulatory and Practical Issues to consider when adopting descentralized clinical trials: recommendations From the clinical Trials Transformation Initiative. TIRS 54, 779-787, (2020).
– Cragg WJ, Hurley C, Yorke-Edwards V, Stenning SP. Dynamic methods for ongoing assessment of site-level risk in risk-based monitoring of clinical trials: A scoping review. Clin Trials. 2021 Apr; 18(2):245-259.
– Farmaindustria. Criterios de excelencia para la realización de ensayos clínicos. https://www.google.com/search?q=criterios+de+excelencia+para+la+realizacion+de+ensayos+cl%C3%ADnicos&rlz=1C1CHBF_esES833ES833&oq=criterios+de+excelencia+para+la+realizacion+de+ensayos+cl%C3%ADnicos&aqs=chrome..69i57.28594j1j7&sourceid=chrome&ie=UTF-8.
– Encapsia. What are descentralized Trials and Why do they matter so much today? May 17, 2021. https://www.clinicalleader.com/doc/what-are-decentralized-trials-and-why-do-they-matter-so-much-today-0001.
– European Medicines Agency. Guidance on the Management of Clinical Trials during COVID-19. En: https://ec.europa.eu/health/sites/default/files/files/eudralex/vol-10/guidanceclinicaltrials_covid19_en.pdf.
– Farmaindustria. Ensayos Clínicos y lecciones aprendidas. https://www.youtube.com/watch?v=SwRyEPXaAdU.
– Food and Drug Administration. Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency Guidance for Industry, Investigators, and Institutional Review Boards. En: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-public-health-emergency.
– Goldsack JC, Izmailova ES, Menetski JP, Hoffmann SC, Groenen PMA, Wagner J.A. Remote digital monitoring in clinical trials in the time of COVID-19. Nat Rev Drug Discov. 2020 Jun; 19(6):378-379.
– Izmailova ES, Ellis R, Benko C. Remote Monitoring in Clinical Trials During the COVID-19 Pandemic. Clin Transl Sci. 2020 Sep; 13(5):838-841.
– Love SB, Armstrong E, Bayliss C, Boulter M, Fox L, Grumett J, Rafferty P, Temesi B, Wills K, Corkhill A. Monitoring advances including consent: learning from COVID-19 trials and other trials running in UKCRC registered clinical trials units during the pandemic. Trials. 2021 Apr 14;22(1):279.
– Orden SND/293/2020, de 25 de marzo, por la que se establecen condiciones a la dispensación y administración de medicamentos en el ámbito del Sistema Nacional de Salud, ante la situación de crisis sanitaria ocasionada por el COVID-19. BOE núm. 85, de 27 de marzo de 2020, páginas 27500 a 27501.
– Rho. Introduction to descentralized clinical trials. Noviembre 18, 2020. https://www.clinicalleader.com/doc/introduction-to-decentralized-clinical-trials-0001.
– Van Dorn A. COVID-19 and readjusting clinical trials. Lancet. 2020 Aug 22;396(10250):523-524.
– Yamada O, Chiu SW, Takata M, Abe M, Shoji M, Kyotani E, Endo C, Shimada M, Tamura Y, Yamaguchi T. Clinical trial monitoring effectiveness: Remote risk-based monitoring versus on-site monitoring with 100% source data verification. Clin Trials. 2021 Apr; 18(2):158-167.
